Sector: Biopharmaceutical Supply Chain
Investment Date: 2019
Description: Contract Development and Manufacturing for Topical Dermatology Pharmaceuticals
Status: Current
Headquarters: Raleigh, NC
Tergus Pharma is a leading contract development and manufacturing business for topical dermatology pharmaceuticals. Tergus provides formulation development, in vitro permeating testing (IVPT), in vitro release testing (IVRT), skin biology, analytical services, and clinical manufacturing services for branded and generic dermatology products. Great Point’s investment will allow Tergus to build a state of the art commercial manufacturing facility in Raleigh, NC.